This e-book is sponsored by Angelini Pharma, Inc.
Chronic non-healing wounds represent an enormous problem. An estimated 6 million patients in the U.S. have chronic wounds from various etiologies, representing an estimated annual $20 billion dollar burden on the healthcare system.
BioPad is a 100% equine Type-1 collagen primary wound dressing used to treat hard-to-heal wounds. The BioPad collagen dressing has the highest collagen content on the market up to 5 times the amount of collagen. Its structure provides more real native collagen to “feed” elastase and active MMPs, speeding-up the fibroblast depletion of autologous collagen.
Case studies have shown that BioPad can speed wound healing, even in cases of chronic, non-healing wounds. Using BioPad as the first choice for treatment could help in the prevention of chronic wounds, relieving patient suffering and reducing the impact on the healthcare system.